{"component": "definition", "props": {"groups": [{"samples": [{"hash": "iGyZZPAGnKO", "uri": "/contracts/iGyZZPAGnKO#icf", "label": "Credit and Guaranty Agreement (American Airlines, Inc.)", "score": 37.1834360027, "published": true}, {"hash": "4xryGUMKhYd", "uri": "/contracts/4xryGUMKhYd#icf", "label": "Credit and Guaranty Agreement (American Airlines, Inc.)", "score": 37.1834360027, "published": true}, {"hash": "3BrnWRn6pjO", "uri": "/contracts/3BrnWRn6pjO#icf", "label": "Credit and Guaranty Agreement (American Airlines, Inc.)", "score": 37.1834360027, "published": true}], "snippet": "means ICF International, formerly known as ICF SH&E, Inc.", "size": 38, "snippet_links": [], "hash": "6f329681ce859a2ac3b90eabf1c0ed0d", "id": 1}, {"samples": [{"hash": "eEyB74PKPjq", "uri": "/contracts/eEyB74PKPjq#icf", "label": "Clinical Trial Agreement (Lixte Biotechnology Holdings, Inc.)", "score": 35.4503746033, "published": true}, {"hash": "bw0cQYlgWaj", "uri": "/contracts/bw0cQYlgWaj#icf", "label": "Clinical Trial Agreement", "score": 31.4039955139, "published": true}, {"hash": "fyN39uBC62S", "uri": "/contracts/fyN39uBC62S#icf", "label": "Clinical Trial Agreement", "score": 29.8827571869, "published": true}], "snippet": "means the Informed Consent Form as approved by the Ethics Committee, in which the Clinical Trial Subject consents to his participation in the Clinical Trial;", "size": 21, "snippet_links": [{"key": "informed-consent-form", "type": "clause", "offset": [10, 31]}, {"key": "approved-by", "type": "definition", "offset": [35, 46]}, {"key": "ethics-committee", "type": "definition", "offset": [51, 67]}, {"key": "clinical-trial-subject", "type": "definition", "offset": [82, 104]}], "hash": "d59649ba5a56fcc4bfaefe2e215c98e7", "id": 2}, {"samples": [{"hash": "iPuY6dn8p80", "uri": "/contracts/iPuY6dn8p80#icf", "label": "Term Loan Credit and Guaranty Agreement (United Airlines, Inc.)", "score": 35.1409988403, "published": true}, {"hash": "dSAkzx2zmh2", "uri": "/contracts/dSAkzx2zmh2#icf", "label": "Revolving Credit and Guaranty Agreement (United Airlines, Inc.)", "score": 35.1409988403, "published": true}, {"hash": "iQJdUd6sTtQ", "uri": "/contracts/iQJdUd6sTtQ#icf", "label": "Indenture (United Airlines, Inc.)", "score": 32.3045845032, "published": true}], "snippet": "means ICF International.", "size": 16, "snippet_links": [], "hash": "4e9c9b440780fb7ba794b9810e9e6290", "id": 3}, {"samples": [{"hash": "bT28Q9D3o7e", "uri": "/contracts/bT28Q9D3o7e#icf", "label": "Clinical Collaboration and Supply Agreement (Olema Pharmaceuticals, Inc.)", "score": 34.3497619629, "published": true}, {"hash": "jJlT0joVHmw", "uri": "/contracts/jJlT0joVHmw#icf", "label": "Clinical Trial Collaboration and Supply Agreement (Intensity Therapeutics, Inc.)", "score": 32.8220405579, "published": true}, {"hash": "eyYavEt1ox5", "uri": "/contracts/eyYavEt1ox5#icf", "label": "Clinical Trial Collaboration and Supply Agreement (Aveo Pharmaceuticals, Inc.)", "score": 32.3538665771, "published": true}], "snippet": "shall have the meaning set forth in Section 5.1(f).", "size": 16, "snippet_links": [], "hash": "7aa3f029ab49806df81e8802dde883d3", "id": 4}, {"samples": [{"hash": "1XhzZ2cxP3A", "uri": "https://rdso.indianrailways.gov.in/uploads/final%20demu%20spec%20with%20amendment%20sheet%20as%20on%2001dec2022.pdf", "label": "Amendment", "score": 15.4955511093, "published": false}, {"hash": "4iJmPRCGREd", "uri": "https://rdso.indianrailways.gov.in/works/uploads/File/Final%20draft%20Spec-3Phase-DEMU-1600HP%20August%202020%20(rev04)17_08_2020.pdf", "label": "rdso.indianrailways.gov.in", "score": 10.3127994537, "published": false}, {"hash": "bJFULsa8xQC", "uri": "https://rdso.indianrailways.gov.in/uploads/D_481_1665121887150.pdf", "label": "rdso.indianrailways.gov.in", "score": 9.3723478317, "published": false}], "snippet": "means Integral Coach Factory, Chennai-600038.", "size": 8, "snippet_links": [], "hash": "66b6c2c483f48f92a83bafbd6a3d4308", "id": 5}, {"samples": [{"hash": "5JA6ar15H4M", "uri": "/contracts/5JA6ar15H4M#icf", "label": "Collaboration Agreement (BioNTech SE)", "score": 32.2416152954, "published": true}, {"hash": "8n1hqPgGdOs", "uri": "/contracts/8n1hqPgGdOs#icf", "label": "Collaboration Agreement", "score": 32.0863380432, "published": true}, {"hash": "8iL1py4wbnz", "uri": "/contracts/8iL1py4wbnz#icf", "label": "Collaboration Agreement (BioNTech SE)", "score": 31.5516777039, "published": true}], "snippet": "means an informed consent form that was approved by a qualified Institutional Review Board or Independent Ethics Committee (\u201cIRB / IEC\u201d) in accordance with all applicable Laws and recognized international standards for the protection of human research subjects.", "size": 7, "snippet_links": [{"key": "informed-consent-form", "type": "clause", "offset": [9, 30]}, {"key": "approved-by", "type": "definition", "offset": [40, 51]}, {"key": "a-qualified", "type": "clause", "offset": [52, 63]}, {"key": "institutional-review-board", "type": "clause", "offset": [64, 90]}, {"key": "independent-ethics-committee", "type": "definition", "offset": [94, 122]}, {"key": "in-accordance-with", "type": "definition", "offset": [137, 155]}, {"key": "all-applicable-laws", "type": "definition", "offset": [156, 175]}, {"key": "international-standards", "type": "definition", "offset": [191, 214]}, {"key": "protection-of", "type": "definition", "offset": [223, 236]}, {"key": "human-research-subjects", "type": "clause", "offset": [237, 260]}], "hash": "4cf8c6925748f4f7a566c82bf4ed0aad", "id": 6}, {"samples": [{"hash": "agsec04QWOH", "uri": "https://www.legis.iowa.gov/docs/iac/chapter/03-29-2017.261.173.pdf", "label": "www.legis.iowa.gov", "score": 7.3651304245, "published": false}, {"hash": "wv5HcbcJI7", "uri": "https://www.legis.iowa.gov/docs/iac/rule/261.173.2.pdf", "label": "www.legis.iowa.gov", "score": 4.7310061455, "published": false}, {"hash": "fij1OZkdpXS", "uri": "https://www.legis.iowa.gov/docs/iac/rule/12-24-2014.261.173.2.pdf", "label": "www.legis.iowa.gov", "score": 4.4859685898, "published": false}], "snippet": "means the innovation and commercialization fund created in Iowa Code section 15.412.", "size": 6, "snippet_links": [{"key": "code-section", "type": "definition", "offset": [64, 76]}], "hash": "9d67accf7f9cfc44cdcc9d4ff4e7bb01", "id": 7}, {"samples": [{"hash": "d7aS2rehEjk", "uri": "https://www.unfpa.org/sites/default/files/admin-resource/Procurement%20Procedures%20English%20Oct12%20%5B241012-Rev03%5D.pdf", "label": "www.unfpa.org", "score": 10.3552360535, "published": false}, {"hash": "frmFI5eRxmP", "uri": "https://unfpa.org/sites/default/files/admin-resource/PROC_Regular%20Procurement%20Procedures_0.pdf", "label": "unfpa.org", "score": 7.8610539436, "published": false}, {"hash": "3asfKnhDudB", "uri": "https://www.unfpa.org/sites/default/files/admin-resource/PROC_Regular%20Procurement%20Procedures.pdf", "label": "www.unfpa.org", "score": 7.6611909866, "published": false}], "snippet": "means the UNFPA Internal Control Framework;", "size": 5, "snippet_links": [{"key": "control-framework", "type": "definition", "offset": [25, 42]}], "hash": "b91db0c99c2085a395ccb7c1ce0d130e", "id": 8}, {"samples": [{"hash": "8F9fDyNDYR0", "uri": "http://www.alsaciaexpress.cl/prontus_alsacia/site/artic/20120314/asocfile/20120314182412/alsacia_express_management_report_2q_2012.pdf", "label": "www.alsaciaexpress.cl", "score": 6.3497605324, "published": false}, {"hash": "akCtt0K4jqf", "uri": "http://www.alsaciaexpress.cl/prontus_alsacia/site/artic/20120314/asocfile/20120314181832/alsacia_management_report_1q_2012.pdf", "label": "www.alsaciaexpress.cl", "score": 6.2032852173, "published": false}, {"hash": "h3Y5gf9EQkJ", "uri": "http://www.alsaciasa.cl/prontus_alsacia/site/artic/20120314/asocfile/20120314181832/alsacia_express_management_report_december_2011.pdf", "label": "www.alsaciasa.cl", "score": 6.1594796181, "published": false}], "snippet": "means the frequency fulfillment index (\u00cdndice de Cumplimiento de Frecuencia), which, along with the ICR, is used by the Ministry to measure the performance of Alsacia and Express in relation to their respective Operating Plans. Deviations from Operating Plans decrease ICF, which in turn leads to discounts in funds to be received from the AFT. Alsacia currently accounts for such discounts as reductions to its revenue and Express currently accounts for such discounts as expenses.", "size": 4, "snippet_links": [{"key": "the-ministry", "type": "definition", "offset": [116, 128]}, {"key": "the-performance", "type": "clause", "offset": [140, 155]}, {"key": "in-relation-to", "type": "clause", "offset": [179, 193]}, {"key": "operating-plans", "type": "definition", "offset": [211, 226]}], "hash": "4cb13d26a08d97fb6e56074a6e2b1da8", "id": 9}, {"samples": [{"hash": "dENgPoOlsIb", "uri": "https://www.sec.gov/Archives/edgar/data/1525773/000119312521040121/d121748dex992.htm", "label": "Intelsat S.A.", "score": 16.1156749725, "published": false}, {"hash": "jff5ROiQOOA", "uri": "https://cases.stretto.com/public/X070/10255/PLEADINGS/1025509012180000000009.pdf", "label": "Notice", "score": 14.8316221237, "published": false}, {"hash": "cINC1V9UR6P", "uri": "https://cases.stretto.com/public/X070/10255/CORRESPONDENCE/1025509092150000000003.pdf", "label": "cases.stretto.com", "score": 10.8343601227, "published": false}], "snippet": "means Intelsat Connect Finance S.A., a soci\u00e9t\u00e9 anonyme organized under the laws of the Grand Duchy of Luxembourg.", "size": 4, "snippet_links": [{"key": "the-laws", "type": "definition", "offset": [71, 79]}], "hash": "f7c00816c07e992102e5bc881ae037d8", "id": 10}], "next_curs": "ClASSmoVc35sYXdpbnNpZGVyY29udHJhY3RzciwLEhpEZWZpbml0aW9uU25pcHBldEdyb3VwX3Y1NiIMaWNmIzAwMDAwMDBhDKIBAmVuGAAgAA==", "definition": {"snippet": "means ICF International, formerly known as ICF SH&E, Inc.", "size": 227, "title": "ICF", "id": "icf", "examples": ["Immatics shall provide the Clinical Study Project Committee with a copy of the final <strong>ICF</strong> for the Clinical Study Project Committee\u2019s review and approval, which shall be completed within five Business Days of receipt.", "Immatics shall implement all comments from Moderna regarding the portion of the <strong>ICF</strong> relating to the Clinical Study or any Product Candidate, and any changes to the <strong>ICF</strong> to the extent relating to the Clinical Study or any Product Candidate shall be subject to Moderna\u2019s prior written consent."], "related": [["bci", "BCI", "BCI"], ["fti", "FTI", "FTI"], ["parent", "Parent", "Parent"], ["dbh", "DBH", "DBH"], ["sbi", "SBI", "SBI"]], "related_snippets": [], "updated": "2026-03-11T05:19:41+00:00"}, "json": true, "cursor": ""}}